Brought to you by 
Obalon brings in $20mm via Series D and $10mm term loan
16 Jan 2015
Executive Summary
Obalon Therapeutics Inc. (balloon device for weight loss) raised $20mm in Series D funding from returning backers Domain Associates, InterWest Partners, and Okapi Venture Capital, and new investors Axon Ventures, Bader Sultan & Bros., Mirae Asset Venture Investment, NeoPlux, and Striker Asia Opportunities Fund. Obalon also received a $10mm term loan from Square 1 Bank. Funds will help support US clinical trials of the Obalon balloon as the company prepares it for FDA approval.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Obalon brings in $20mm via Series D and $10mm term loan
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice